PRAMEF33
PRAME family member 33
Also known as: PRA33_HUMAN, PRAMEF33P
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A0A0G2JMD5
- Gene
- PRAMEF33
- Ensembl
- ENSG00000237700
- Chromosome
- 1
- Canonical length
- 474 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable ubiquitin-like ligase-substrate adaptor activity. Predicted to be involved in proteasome-mediated ubiquitin-dependent protein catabolic process. Predicted to be part of Cul2-RING ubiquitin ligase complex. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
474 residues, UniProt reviewed canonical sequence.
>A0A0G2JMD5|PRAMEF33
1 MSLQAPSRLL ELAGQSLLRN QFLTIFTLDE LPREVFPLMF MEAFSMRRFE ALKLMVQAWP
61 FLRLPLGSLM KTPHLETLQA VLRGLDTLVA QKVRPRRWKL QVLDLQDVDE NFWTIWSGAR
121 VLSCSPEAMS KRQTVEDCPR MGEHQPLKVF IDLCLKESTL DECLSYLFGW IHYRRGLVHL
181 CCSKVQNYSM PTSSFRNLLE RIYPDSIQEL EVWKKCSLNK TGKFAPYLSQ MSNLRELFLA
241 FGYERELYVS VQWPCIPDLD SPFLCLYYPQ MLYIKKISNI KEHLEHLLRY LKNPLGAFIF
301 SDAYLADRDM ECLSQYPSLS QLKELRLIHI LMWTTNLQPL GALLEKVAAT LKTLVLKDCR
361 IQDPQLRVLL PALSHCSQLT TFNFHGNETS MNALKDLLRH TRGLSKLGLE LYPAPLESLD
421 YKGHVNWEIL TPIRAELMRT LREVRQPKRI FFGPVPCPTC GSWPSEKVDF HLCSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRAMEF33 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 1 nTPM
Expression across tissuesHPA
Tissue
- liver: 1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
- appendix: 0 nTPM
- basal ganglia: 0 nTPM
Single-cell type
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
- alveolar cells type 1: 0 nCPM
- alveolar cells type 2: 0 nCPM
- b-cells: 0 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
OntologyGO
Biological processes
- negative regulation of apoptotic process
- negative regulation of cell differentiation
- negative regulation of DNA-templated transcription
- positive regulation of cell population proliferation
- proteasome-mediated ubiquitin-dependent protein catabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRAMEF33 as an antibody target. Whether an autoantibody or antibody against PRAMEF33 could matter depends on whether native PRAMEF33 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRAMEF33 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRAMEF33 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...